Boggs DL - Search Results

1

Treatment of hyperprolactinemia and gynecomastia with adjunctive aripiprazole in 2 men receiving long-acting injectable antipsychotics.

Boggs DL, Ranganathan M, Boggs AA, Bihday CM, Peluse BE, D'Souza DC. Boggs DL, et al. Prim Care Companion CNS Disord. 2013;15(4):PCC.13l01519. doi: 10.4088/PCC.13l01519. Prim Care Companion CNS Disord. 2013. PMID: 24392257 Free PMC article. No abstract available.

2

Pilot study of intravenous nicotine effects on cognitive performance in schizophrenia.

Boggs DL, Ranganathan M, Sewell RA, Madonick S, D'Souza DC. Boggs DL, et al. Schizophr Res. 2013 Oct;150(1):323-4. doi: 10.1016/j.schres.2013.07.045. Epub 2013 Aug 13. Schizophr Res. 2013. PMID: 23953216 Clinical Trial. No abstract available.

3

Delta-9-tetrahydrocannabinol and cannabidiol: Separating the chemicals from the "weed," a pharmacodynamic discussion.

Boggs DL, Peckham A, Boggs AA, Ranganathan M. Boggs DL, et al. Ment Health Clin. 2016 Nov 3;6(6):277-284. doi: 10.9740/mhc.2016.11.277. eCollection 2016 Nov. Ment Health Clin. 2016. PMID: 29955482 Free PMC article.

4

Minimal effects of prolonged smoking abstinence or resumption on cognitive performance challenge the "self-medication" hypothesis in schizophrenia.

Boggs DL, Surti TS, Esterlis I, Pittman B, Cosgrove K, Sewell RA, Ranganathan M, D'Souza DC. Boggs DL, et al. Schizophr Res. 2018 Apr;194:62-69. doi: 10.1016/j.schres.2017.03.047. Epub 2017 Apr 6. Schizophr Res. 2018. PMID: 28392208 Free PMC article.

5

The effects of cannabidiol (CBD) on cognition and symptoms in outpatients with chronic schizophrenia a randomized placebo controlled trial.

Boggs DL, Surti T, Gupta A, Gupta S, Niciu M, Pittman B, Schnakenberg Martin AM, Thurnauer H, Davies A, D'Souza DC, Ranganathan M. Boggs DL, et al. Psychopharmacology (Berl). 2018 Jul;235(7):1923-1932. doi: 10.1007/s00213-018-4885-9. Epub 2018 Apr 5. Psychopharmacology (Berl). 2018. PMID: 29619533 Clinical Trial.

6

The dose-dependent psychomotor effects of intravenous delta-9-tetrahydrocannabinol (Δ⁹-THC) in humans.

Boggs DL, Cortes-Briones JA, Surti T, Luddy C, Ranganathan M, Cahill JD, Sewell AR, D'Souza DC, Skosnik PD. Boggs DL, et al. J Psychopharmacol. 2018 Dec;32(12):1308-1318. doi: 10.1177/0269881118799953. Epub 2018 Sep 26. J Psychopharmacol. 2018. PMID: 30255720 Clinical Trial.

7

Clinical and Preclinical Evidence for Functional Interactions of Cannabidiol and Δ⁹-Tetrahydrocannabinol.

Boggs DL, Nguyen JD, Morgenson D, Taffe MA, Ranganathan M. Boggs DL, et al. Neuropsychopharmacology. 2018 Jan;43(1):142-154. doi: 10.1038/npp.2017.209. Epub 2017 Sep 6. Neuropsychopharmacology. 2018. PMID: 28875990 Free PMC article. Review.

8

Going up in smoke? A review of nAChRs-based treatment strategies for improving cognition in schizophrenia.

Boggs DL, Carlson J, Cortes-Briones J, Krystal JH, D'Souza DC. Boggs DL, et al. Curr Pharm Des. 2014;20(31):5077-92. doi: 10.2174/1381612819666131216121019. Curr Pharm Des. 2014. PMID: 24345265 Free PMC article. Review.

9

Psychoactive Substance Use by Adults With Schizophrenia Before and During Cannabis Withdrawal.

Koola MM, Kelly DL, McMahon RP, Boggs DL, Liu F, Gorelick DA. Koola MM, et al. Among authors: boggs dl. Prim Care Companion CNS Disord. 2016 Sep 1;18(5):10.4088/PCC.16l01959. doi: 10.4088/PCC.16l01959. Prim Care Companion CNS Disord. 2016. PMID: 27835727 Free PMC article. No abstract available.

10

The Overdose Education and Naloxone Distribution Program at a VA Hospital.

Peckham AM, Boggs DL. Peckham AM, et al. Among authors: boggs dl. Fed Pract. 2016 Nov;33(11):28-31. Fed Pract. 2016. PMID: 30766147 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

37 results

Search Page

Filters